McClarren Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-119
Closed -$6K – 385
2023
Q4
$6K Buy
119
+1
+0.8% +$49 ﹤0.01% 292
2023
Q3
$5K Hold
118
– – ﹤0.01% 280
2023
Q2
$6K Sell
118
-1
-0.8% -$55 0.01% 277
2023
Q1
$6K Hold
119
– – 0.01% 263
2022
Q4
$6K Sell
119
-1
-0.8% -$51 0.01% 271
2022
Q3
$5K Buy
+120
New +$6.23K 0.01% 256
2022
Q2
– Sell
-120
Closed -$7K – 133
2022
Q1
$7K Sell
120
-1
-0.8% -$60 0.01% 218
2021
Q4
$8K Buy
+121
New +$7.75K 0.01% 247

Other funds holding IHI

McClarren Financial Advisors's IHI Position: Q1 2024 in Review

McClarren Financial Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2024, closing a stake of 119 shares — an estimated $6K sold.

McClarren Financial Advisors first reported a position in IHI in Q4 2021 and held it in 8 quarters. The position peaked at $8K in Q4 2021. 584 funds tracked by Wall St. Rank hold IHI as of Q1 2024.

  • McClarren Financial Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2024 after selling out during the quarter.
  • McClarren Financial Advisors sold 119 iShares US Medical Devices ETF shares in Q1 2024, an estimated $6K.
  • McClarren Financial Advisors first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 8 quarters.
  • McClarren Financial Advisors's iShares US Medical Devices ETF position peaked at $8K in Q4 2021.
  • 584 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2024.

Based on McClarren Financial Advisors's 13F filing for Q1 2024, filed 3 May 2024.